MedPath

A Single Group Study to Evaluate the Efficacy of Bye Bye Bloat Capsules in Relieving Bloating and Promoting Healthy Digestion.

Not Applicable
Completed
Conditions
Digestion
Digestive Health
Interventions
Dietary Supplement: Bye Bye Bloat Capsules
Registration Number
NCT06516744
Lead Sponsor
Love Wellness
Brief Summary

This virtual single-group study aims to evaluate the efficacy of Bye Bye Bloat Capsules in relieving hormonal and food-related bloating and promoting healthy digestion. The study will last 4 weeks, involving 40 female participants aged 18+ who will take two capsules after meals and during times of bloating. Measurements and questionnaires will be completed at Baseline, first use, Week 2, and Week 4.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
40
Inclusion Criteria
  • Women aged 18+
  • Self-reported concerns with bloating after eating
  • Issues with hormonal bloating
  • Generally healthy without uncontrolled chronic diseases
  • Willing to avoid using digestive health remedies and other oral supplements during the study
Exclusion Criteria
  • Pre-existing chronic conditions preventing adherence to the protocol
  • Undergoing procedures related to digestive health
  • Started new medications or supplements targeting digestive health in the past 3 months
  • Severe allergic reactions requiring an Epi-Pen
  • Pregnant, breastfeeding, or attempting to conceive
  • Unwilling to follow the study protocol
  • Recent surgeries or planned surgeries during the study
  • Diagnosed gastrointestinal disorders
  • Recent changes in hormonal birth control use

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Bye Bye Bloat CapsulesBye Bye Bloat CapsulesParticipants will take 2 Bye Bye Bloat capsules immediately after eating (when they feel full and bloated) at least 3 times a week. They may also take the product during times of hormonal bloating. The study will last for 4 weeks, with questionnaires and waist measurements completed at Baseline, first use, Week 2, and Week 4.
Primary Outcome Measures
NameTimeMethod
Reduction in BloatingBaseline, first use, Week 2, and Week 4

Evaluation of parameters associated with hormonal and food-related bloating through self-reported questionnaires taken at Baseline, first use, Week 2, and Week 4.

Secondary Outcome Measures
NameTimeMethod
Improvement in Digestion and Mental Well-beingBaseline, first use, Week 2, and Week 4

Assessment of changes in participant perception of digestion, gas, mental health, and well-being associated with bloating through self-reported questionnaires taken at Baseline, first use, Week 2, and Week 4.

Trial Locations

Locations (1)

Citruslabs

🇺🇸

Santa Monica, California, United States

© Copyright 2025. All Rights Reserved by MedPath